Intenzivna nega
Prevention of Drug-Induced Anemia or Thrombocytopenia
Mechanisms and etiologies of thrombocytopenia in the intensive care unit: impact of extensive investigations. (odpre novo okno)
Vir: Ann Intensive Care 2014;4:24.
Indeksirano: PubMed 25593741
DOI: 10.1186/s13613-014-0024-x
https://www.ncbi.nlm.nih.gov/pubmed/25593741 (odpre novo okno)
Drugs affecting coagulation. (odpre novo okno)
Vir: Anaesth Intensive Care Med 2010;11(6):247-53.
Indeksirano: EMBASE 2010500347
DOI: 10.1016/j.mpaic.2010.03.004
https://dx.doi.org/10.1016/j.mpaic.2010.03.004 (odpre novo okno)
Approach to the diagnosis and management of drug-induced immune thrombocytopenia. (odpre novo okno)
Vir: Transfus Med Rev 2013;27(3):137-45.
Indeksirano: PubMed 23845922
DOI: 10.1016/j.tmrv.2013.05.005
https://www.ncbi.nlm.nih.gov/pubmed/23845922 (odpre novo okno)
Drug-induced immune thrombocytopenia. (odpre novo okno)
Vir: N Engl J Med 2007;357(6):580-7.
Indeksirano: PubMed 17687133
DOI: 10.1056/NEJMra066469
https://www.ncbi.nlm.nih.gov/pubmed/17687133 (odpre novo okno)
Thrombocytopenia in the intensive care unit patient. (odpre novo okno)
Vir: Hematology Am Soc Hematol Educ Program 2010;2010:135-43.
Indeksirano: PubMed 21239783
DOI: 10.1182/asheducation-2010.1.135
https://www.ncbi.nlm.nih.gov/pubmed/21239783 (odpre novo okno)
Variability of findings in drug-induced immune haemolytic anaemia: experience over 20 years in a single centre. (odpre novo okno)
Vir: Transfus Med Hemother 2015;42(5):333-9.
Indeksirano: PubMed 26696803
DOI: 10.1159/000440673
https://www.ncbi.nlm.nih.gov/pubmed/26696803 (odpre novo okno)
Anemia, bleeding, and blood transfusion in the intensive care unit: causes, risks, costs, and new strategies. (odpre novo okno)
Vir: Am J Crit Care 2013;22(6 Suppl):eS1-13.
Indeksirano: PubMed 24186829
DOI: 10.4037/ajcc2013729
https://www.ncbi.nlm.nih.gov/pubmed/24186829 (odpre novo okno)
Drug-induced thrombocytopenia in critically ill patients. (odpre novo okno)
Vir: Crit Care Med 2010;38(6 Suppl):S145-54.
Indeksirano: PubMed 20502168
DOI: 10.1097/CCM.0b013e3181de0b88
https://www.ncbi.nlm.nih.gov/pubmed/20502168 (odpre novo okno)
Recurrent acute thrombocytopenia in the hospitalized patient: sepsis, DIC, HIT, or antibiotic-induced thrombocytopenia. (odpre novo okno)
Vir: Am J Hematol 2010;85(1):71-4.
Indeksirano: PubMed 19802882
DOI: 10.1002/ajh.21536
https://www.ncbi.nlm.nih.gov/pubmed/19802882 (odpre novo okno)
Drugs that affect platelet function. (odpre novo okno)
Vir: Semin Thromb Hemost 2012;38(8):865-83.
Indeksirano: PubMed 23111864
DOI: 10.1055/s-0032-1328881
https://www.ncbi.nlm.nih.gov/pubmed/23111864 (odpre novo okno)
Drug-induced anemia and other red cell disorders: a guide in the age of polypharmacy. (odpre novo okno)
Vir: Curr Clin Pharmacol 2011;6(4):295-303.
Indeksirano: PubMed 22082327
https://www.ncbi.nlm.nih.gov/pubmed/22082327 (odpre novo okno)
Vancomycin-induced immune thrombocytopenia. (odpre novo okno)
Vir: N Engl J Med 2007;356(9):904-10.
Indeksirano: PubMed 17329697
DOI: 10.1056/NEJMoa065066
https://www.ncbi.nlm.nih.gov/pubmed/17329697 (odpre novo okno)
Evaluation and management of drug-induced thrombocytopenia in the acutely ill patient. (odpre novo okno)
Vir: Pharmacotherapy 2000;20(3):292-307.
Indeksirano: PubMed 10730685
DOI: 10.1592/phco.20.4.292.34883
https://www.ncbi.nlm.nih.gov/pubmed/10730685 (odpre novo okno)